Thrive Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Thrive Capital
- 1(12 months)
- thrivecap.com
- Update Information
More venture news
- 26 Aug 2026
BreedrBreedr unlocks £20m Series B led by Partech to digitalise the global cattle supply chain
Series BAgriculture - 3 Aug 2026
OlixOLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production
Series BDeep Tech - 5 Aug 2026
MironidMironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences
